BioSpace News Archive

The global insomnia market is expected to witness a growth in the years to come on account of the increasing efficiency of drugs, brought by formulations that increase the bioavailability of a drug.

Scorpion Biological Services, a biopharmaceutical contract development and manufacturing organization and contract research organization, announced the appointment of Stephan Kutzer, Ph.D. as its Interim Chief Executive Officer.

Dr. Reddy’s Laboratories Ltd. announced the launch of Dr. Reddy’s Sorafenib Tablets, USP, 200 mg, a therapeutic generic equivalent of Nexavar® Tablets in the U.S. market following the approval by the U.S. Food and Drug Administration.

Hyperfine, Inc., creator of the Swoop® Portable MR Imaging System™, the world’s first US FDA-cleared portable magnetic resonance imaging device, announced that it has completed registration and notification of the device in Australia and New Zealand.

Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors.

Genexine announced that its partner, I-Mab, recently completed patient enrollment in a phase 3 clinical trial of its proprietary long-acting growth hormone, eftansomatropin alfa, also known as GX-H9/TJ101, in China, taking it one step closer to commercialization in a key market.

MolecuLight Corp., the leader in point-of-care fluorescence imaging for the real-time detection of bacteria in wounds, announces it has been awarded a new group purchasing agreement with Premier, Inc.

Kintor Pharmaceutical Limited announced that its “clinical trial cooperative research and development and overseas application demonstration of the anti-COVID-19 drug " project was selected as one of the Belt and Road Innovation Cooperation Projects and was included in the list of proposed projects for special fund supported by the Jiangsu Provincial Department of Science and Technology.

Bioprocess technology is a vital part of biotechnology that deals with processes combining the complete living matter or its components with nutrients to make specialty chemicals, reagents, and biotherapeutics.

Wilmington, Delaware, United States: The rising efforts by the pharmaceutical manufacturers and drug developers across the world on development of novel therapies aimed at treating various infectious diseases is one of the strongest motivators for the growth in the global antibiotics market in coming years.